Ephrin-A4/EFNA4 hFc Chimera, Human
| $260.00 | |
| Z05257-100 | |
|
|
|
|
|
|
|
|
|
| Ask us a question | |
IVD Raw Materials
| $260.00 | |
| Z05257-100 | |
|
|
|
|
|
|
|
|
|
| Ask us a question | |
| Species | Human | ||||
| Protein Construction |
|
||||
| Purity | > 95% as determined by BisTris PAGE | ||||
| Endotoxin Level | Less than 1EU per μg by the LAL method. | ||||
| Biological Activity | Measured by its binding ability in a functional ELISA. Test result was comparable to standard batch. | ||||
| Expression System | HEK293 | ||||
| Theoretical Molecular Weight | 43.1 kDa | ||||
| Apparent Molecular Weight | Due to glycosylation, the protein migrates to 50-60 kDa based on Bis-Tris PAGE result. | ||||
| Formulation | Lyophilized from 0.22μm filtered solution in PBS (pH 7.4). | ||||
| Reconstitution | Centrifuge the tube before opening. Reconstituting to a concentration more than 100 μg/ml is recommended. Dissolve the lyophilized protein in distilled water. | ||||
| Storage & Stability | Upon receiving, the product remains stable for 6 months at -20℃ or below. Upon reconstitution, the product should be stable for 3 months at -80℃. Avoid repeated freeze-thaw cycles. |
Immobilized Human EphA7, His Tag at 2 μg/ml (100 μl/well) on the plate. Dose response curve for Ephrin-A4/EFNA4 hFc Chimera, Human, hFc Tag with the EC50 of 3.5ng/ml determined by ELISA. »
The purity of Ephrin-A4/EFNA4 hFc Chimera, Human is greater than 95% as determined by SEC-HPLC. »
Ephrin-A4/EFNA4 hFc Chimera, Humanon Bis-Tris PAGE under reduced condition. The purity is greater than 95%. »
| Target Background | Ephrin A4 is one of the ephrin ligand molecules belonging to the tyrosine kinases receptor family. It was originally identified in a T-lymphoma cell line and seen to be expressed in human adult tissue as well as several tumor types. The cytoplasmic pattern of ephrin A4 could identify a subgroup of primary osteosarcoma patients with a high liability for progression, poor prognosis, and inferior response to chemotherapy. |
| Synonyms | Ephrin-A4; Ephrin A4; LERK-4; EFNA4; EPLG4; EFL4 |
For research use only. Not intended for human or animal clinical trials, therapeutic or diagnostic use.